KI and MSD in patient-centred research partnership
In November 2016, Karolinska Institutet entered a five-year research collaboration with pharmaceutical company MSD, a subsidiary of Merck and Co. Inc. The aim of the venture is to improve conditions for clinical research in the future and support product development by encouraging patient-centred studies – that is, studies on how approved drugs work in the real clinical world, a concept known as Real World Evidence.
About the partnership
About the partnership
Research areas for the partnership.
Steering group KI - MSD
Steering group KI - MSD
Here is the steering group for the collaboration presented.
Films and press releases
Films and press releases
Listen to interviews about the collaboration and about innovations in Sweden.
Projects
Projects
Read about our projects.